NOTE: In order to attend the event, it is necessary to register in the registration system (REGISTRATION button). If you want to hold bilateral meetings, you should also register with the B2B tool (MATCHMAKING button) and schedule the meetings you want .

The Health and Biotechnology sector (cosmetics, toiletries, pharmaceuticals, food, chemistry and health services, among others) has been identified as one of the strategic sectors for Brazil, in order to face in a better way, the challenges of Health and Biotechnology sector.

OBJECTIVES:

Identify the challenges in the Health and Biotechnology sector in Brazil and generate spaces and mechanisms to help transform these challenges into sustainable collaboration between SMEs from Europe and Brazil to develop technology-based business opportunities.

Consolidate collaboration areas in the business opportunities based in technology and innovation.

Provide a space to find the right partners to overcome existing and future market challenges.

Link agents supporting business opportunity generation, such as financial bodies, market and technology experts, initiatives for the promotion of business between Brazil and Europe, etc.

Generate bilateral meetings between potential European and Brazilian partners in order to promote the co-generation of specific opportunities.

Brazil is a hub used by foreign health companies to penetrate the Latin American market. Brazil is the largest market in South America, accounting for 40% of demand. The country is also part of regional trade agreements allowing Brazilian based exporters to sell pharmaceuticals duty free or with highly preferential conditions within Latin America. Furthermore, regulations allow most pharmaceuticals and medical devices made in Brazil to be sold directly in most Brazilian export markets. Further opportunities exist in the area of e-health/m-health which is a high growth market in Brazil. The biotechnology sector has over 230 companies serving a $6-7 billion market (2016).

Brazil has consolidated its position as a strong and attractive global player with a high degree of economic diversification and is currently the seventh largest economy in the world. Economic development in recent years has resulted in an expanded mass consumer market and increased social equality, an environment of institutional stability and increased social cohesion. The increase in purchasing power and investment opportunities in sectors like health, biotechnology, oil and natural gas, electricity generation and transmission, real estate and agribusiness makes Brazil an attractive choice for investment. The country is currently the sixth biggest Foreign Direct Investment (FDI) recipient in the world (UNCTAD, 2016).

This event is the third that the ELAN Network has organised in Brazil. In 2016, more than 50 bilateral meetings were held and over 30 business opportunities were identified between European and Brazilian SMEs.

ATTENDEES FROM BRAZIL AND EUROPE:

Companies interested in generating technology-based business opportunities (TBBOs) within the framework of the country challenges identified in the Health and Biotechnology sector.

Regional and local governments.

Technological centres, universities, research institutes and other knowledge-based organisations.

Clusters, business associations and other organisations supporting business.

MAIN ACTIVITIES:

Identification of challenges in Brazil in the Health and Biotechnology sector.